These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28323995)

  • 1. Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.
    Hundemer GL; Baudrand R; Brown JM; Curhan G; Williams GH; Vaidya A
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1835-1843. PubMed ID: 28323995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.
    Brown JM; Robinson-Cohen C; Luque-Fernandez MA; Allison MA; Baudrand R; Ix JH; Kestenbaum B; de Boer IH; Vaidya A
    Ann Intern Med; 2017 Nov; 167(9):630-641. PubMed ID: 29052707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuum of Renin-Independent Aldosteronism in Normotension.
    Baudrand R; Guarda FJ; Fardella C; Hundemer G; Brown J; Williams G; Vaidya A
    Hypertension; 2017 May; 69(5):950-956. PubMed ID: 28289182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
    Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
    Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tp-e interval, Tp-e/QT and Tp-e/QTc ratio in hypertensive patients with primary aldosteronism.
    Demirtas D; Sumbul HE; Bulut A; Demirtas AO; Gulumsek E; Koca H; Icen YK; Koc M
    Clin Exp Hypertens; 2020; 42(1):93-98. PubMed ID: 31204516
    [No Abstract]   [Full Text] [Related]  

  • 6. The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism.
    Vecchiola A; Fuentes CA; Barros ER; Martínez-Aguayo A; García H; Allende F; Solari S; Olmos R; Carvajal C; Tapia-Castillo A; Campino C; Kalergis AM; Baudrand R; Fardella CE
    Am J Hypertens; 2019 Apr; 32(5):468-475. PubMed ID: 30753255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model.
    Ibrahim HN; Hostetter TH
    J Am Soc Nephrol; 2000 Apr; 11(4):625-631. PubMed ID: 10752521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Aldosterone in Obesity-Related Hypertension.
    Kawarazaki W; Fujita T
    Am J Hypertens; 2016 Apr; 29(4):415-23. PubMed ID: 26927805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
    Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
    Schwartz GL; Turner ST
    Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in the diagnosis and treatment of primary aldosteronism.
    Yoshida Y; Shibata H
    Hypertens Res; 2023 Jul; 46(7):1738-1744. PubMed ID: 37198444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary aldosteronism in normokalemic patients with adrenal incidentalomas.
    Bernini G; Moretti A; Argenio G; Salvetti A
    Eur J Endocrinol; 2002 Apr; 146(4):523-9. PubMed ID: 11916621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monogenic hypertension].
    Bähr V; Oelkers W; Diederich S
    Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system.
    Komiya I; Yamada T; Takasu N; Asawa T; Akamine H; Yagi N; Nagasawa Y; Ohtsuka H; Miyahara Y; Sakai H; Sato A; Aizawa T
    J Hypertens; 1997 Jan; 15(1):65-72. PubMed ID: 9050972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomous Aldosterone Secretion as a Subclinical Form of Primary Aldosteronism: Pathogenesis and Clinical Significance.
    Kmieć P; Sworczak K
    Exp Clin Endocrinol Diabetes; 2022 Jan; 130(1):7-16. PubMed ID: 34614533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid antagonism and cardiac hypertrophy.
    Nagata K
    Curr Hypertens Rep; 2008 Jun; 10(3):216-21. PubMed ID: 18765093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension.
    Lonati C; Bassani N; Gritti A; Biganzoli E; Morganti A
    J Hypertens; 2014 Mar; 32(3):627-34. PubMed ID: 24445391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.